He Guangda, Ji Runqing, Huo Xiqian, Su Xiaoming, Ge Jinzhuo, Li Wei, Lei Lubi, Pu Boxuan, Tian Aoxi, Liu Jiamin, Zhang Lihua, Wu Yongjian
National Clinical Research Center for Cardiovascular Diseases, NHC Key Laboratory of Clinical Research for Cardiovascular Medications, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, National Center for Cardiovascular Diseases, Beijing, People's Republic of China.
Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
J Inflamm Res. 2023 Jan 28;16:359-371. doi: 10.2147/JIR.S387534. eCollection 2023.
Inflammation contributes to the progression of heart failure (HF). However, long-term inflammatory trajectories and their associations with outcomes in patients with acute HF remain unclear.
Data was obtained from the China Patient-Centered Evaluative Assessment of Cardiac Events Prospective Heart Failure Study, and high-sensitivity C-reactive protein (hsCRP) was used to reflect the inflammatory level. Only patients who survived over 12-month and had hsCRP data at admission, 1-, and 12-month after discharge were included. The latent class trajectory modeling was used to characterize hsCRP trajectories. Multivariable Cox regression models were used to explore the association between hsCRP trajectories and following mortality.
Totally, 1281 patients with a median 4.77 (interquartile range [IQR]: 4.24-5.07) years follow-up were included. The median age was 64 years (IQR: 54-73 years); 453 (35.4%) were female. Four distinct inflammatory trajectories were characterized: persistently low (n = 419, 32.7%), very high-marked decrease (n = 99, 7.7%), persistently high (n = 649, 50.7%), and persistently very high (n = 114, 8.9%). Compared with the persistently low trajectory, the all-cause mortality was increased in a graded pattern in the persistently high (hazard ratio [HR]: 1.59, 95% confidence interval [CI]: 1.23-2.07) and persistently very high (HR: 2.56, 95% CI: 1.83-3.70) trajectories; nevertheless, the mortality was not significantly increased in very high-marked decrease trajectory (HR: 0.94, 95% CI: 0.57-1.54).
Four distinct inflammatory trajectories were identified among patients with acute HF who survived over 12-month. Patients with persistently high and very high trajectories had significantly higher mortality than those with the persistently low trajectory.
炎症促进心力衰竭(HF)的进展。然而,急性HF患者的长期炎症轨迹及其与预后的关联仍不清楚。
数据来自中国以患者为中心的心脏事件评估前瞻性心力衰竭研究,采用高敏C反应蛋白(hsCRP)反映炎症水平。仅纳入存活超过12个月且在入院时、出院后1个月和12个月有hsCRP数据的患者。采用潜在类别轨迹模型来描述hsCRP轨迹。使用多变量Cox回归模型探讨hsCRP轨迹与后续死亡率之间的关联。
总共纳入1281例患者,中位随访时间为4.77年(四分位间距[IQR]:4.24 - 5.07年)。中位年龄为64岁(IQR:54 - 73岁);453例(35.4%)为女性。确定了四种不同的炎症轨迹:持续低水平(n = 419,32.7%)、极高水平且显著下降(n = 99,7.7%)、持续高水平(n = 649,50.7%)和持续极高水平(n = 114,8.9%)。与持续低水平轨迹相比,持续高水平(风险比[HR]:1.59,95%置信区间[CI]:1.23 - 2.07)和持续极高水平(HR:2.56,95% CI:1.83 - 3.70)轨迹的全因死亡率呈分级增加;然而,极高水平且显著下降轨迹的死亡率未显著增加(HR:0.94,95% CI:0.57 - 1.54)。
在存活超过12个月的急性HF患者中识别出四种不同的炎症轨迹。持续高水平和极高水平轨迹的患者死亡率显著高于持续低水平轨迹的患者。